Repigmentation was seen in 40 of 56 patients (71%), with mean onset at 2 months. They concluded that: “The efficacy and safety of topical PGE2 make it a promising therapy for localized stable vitiligo.”

Wherever you live, at Loyola University Chicago we want to hear about your case of vitiligo. This helps us direct our research, and to find support for our current thoughts on progressive depigmentation.

U.S. National Institutes of Health to carry out the largest vitiligo research study ever undertaken, the international VitGene consortium genome-wide association study, aiming to identify susceptibility genes for generalized vitiligo